Thymic carcinoma natural history, complications and prognosis: Difference between revisions

Jump to navigation Jump to search
Line 3: Line 3:
{{CMG}}; {{AE}} {{AL}}{{PSD}}
{{CMG}}; {{AE}} {{AL}}{{PSD}}
==Overview==
==Overview==
Thymic carcinomas are generally considered indolent tumors due to long recurrence intervals (median of 68 months). The most common sites of distant recurrence are [[lung]], [[liver]], [[bone]], [[kidney]], [[brain]], and [[bone marrow]].<ref name="www.ncbi.nlm.nih.gov">{{Cite web  | last =  | first =  |title = Recurrence of thymoma: clinicopathological feat... [J Surg Oncol. 2001] - PubMed - NCBI | url = http://www.ncbi.nlm.nih.gov/pubmed/11745803 | publisher =  | date =  | accessdate = }}</ref> The most important factor for prognosis is the stage and grade of the thymic carcinoma. The 5-year and 10-year overall survival rates in patients with thymic carcinoma are 38% and 28%, respectively.<ref name="Ogawa-2002">{{Cite journal  | last1 = Ogawa | first1 = K. | last2 = Toita | first2 = T. | last3 = Uno | first3 = T. | last4 = Fuwa | first4 = N. | last5 = Kakinohana | first5 = Y. | last6 = Kamata | first6 = M. | last7 = Koja | first7 = K. | last8 = Kinjo | first8 = T. | last9 = Adachi | first9 = G. | title = Treatment and prognosis of thymic carcinoma: a retrospective analysis of 40 cases. | journal = Cancer | volume = 94 | issue = 12 | pages = 3115-9 | month = Jun | year = 2002 | doi = 10.1002/cncr.10588 | PMID = 12115342 }}</ref> The subtypes squamous cell carcinoma, mucoepidermoid carcinoma, and basaloid  carcinoma have a better prognosis than other histological subtypes.
Thymic carcinomas are generally considered indolent tumors due to long recurrence intervals (median of 68 months). The most common sites of distant recurrence are [[lung]], [[liver]], [[bone]], [[kidney]], [[brain]], and [[bone marrow]].<ref name="www.ncbi.nlm.nih.gov">{{Cite web  | last =  | first =  |title = Recurrence of thymoma: clinicopathological feat... [J Surg Oncol. 2001] - PubMed - NCBI | url = http://www.ncbi.nlm.nih.gov/pubmed/11745803 | publisher =  | date =  | accessdate = }}</ref> The most important factor for prognosis is the stage and grade of the thymic carcinoma. The 5-year and 10-year overall survival rates in patients with thymic carcinoma are 38% and 28%, respectively.<ref name="Ogawa-2002">{{Cite journal  | last1 = Ogawa | first1 = K. | last2 = Toita | first2 = T. | last3 = Uno | first3 = T. | last4 = Fuwa | first4 = N. | last5 = Kakinohana | first5 = Y. | last6 = Kamata | first6 = M. | last7 = Koja | first7 = K. | last8 = Kinjo | first8 = T. | last9 = Adachi | first9 = G. | title = Treatment and prognosis of thymic carcinoma: a retrospective analysis of 40 cases. | journal = Cancer | volume = 94 | issue = 12 | pages = 3115-9 | month = Jun | year = 2002 | doi = 10.1002/cncr.10588 | PMID = 12115342 }}</ref> The subtypes squamous cell carcinoma, mucoepidermoid carcinoma, and basaloid  carcinoma have a better prognosis than other histological subtypes. There are no reported cases of complications regarding the carcinoma by itself.


==Natural History==
==Natural History==

Revision as of 21:26, 22 July 2019

Thymic Carcinoma Microchapters

Home

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Thymic carcinoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

Echocardiograph and Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Future or Investigational Therapies

Case Studies

Case #1

Thymic carcinoma natural history, complications and prognosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Google Images

American Roentgen Ray Society Images of Thymic carcinoma natural history, complications and prognosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Thymic carcinoma natural history, complications and prognosis

CDC on Thymic carcinoma natural history, complications and prognosis

Thymic carcinoma natural history, complications and prognosis in the news

Blogs on Thymic carcinoma natural history, complications and prognosis

Directions to Hospitals Treating Type page name here

Risk calculators and risk factors for Thymic carcinoma natural history, complications and prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Alejandro Lemor, M.D. [2]Parminder Dhingra, M.D. [3]

Overview

Thymic carcinomas are generally considered indolent tumors due to long recurrence intervals (median of 68 months). The most common sites of distant recurrence are lung, liver, bone, kidney, brain, and bone marrow.[1] The most important factor for prognosis is the stage and grade of the thymic carcinoma. The 5-year and 10-year overall survival rates in patients with thymic carcinoma are 38% and 28%, respectively.[2] The subtypes squamous cell carcinoma, mucoepidermoid carcinoma, and basaloid carcinoma have a better prognosis than other histological subtypes. There are no reported cases of complications regarding the carcinoma by itself.

Natural History

  • Thymic carcinomas are generally considered indolent tumors due to long recurrence intervals (median of 68 months).
  • Overall, for patients diagnosed with a resectable thymic tumor, 16% of them will recur after radical resection, either through local pleural or ganglionar recurrence or through distant metastatic spread.
  • The most common sites of distant recurrence are lung, liver, bone, kidney, brain, and bone marrow.[1]

Complications

  • There are no reported cases of complications regarding the carcinoma by itself.
  • Most complications occur during surgery and biopsy.

Prognosis

  • The most important factor for prognosis is the stage and grade of the thymic carcinoma.
  • The 5-year and 10-year overall survival rates in patients with thymic carcinoma are 38% and 28% respectively.[2]
  • The subtypes squamous cell carcinoma, mucoepidermoid, and basaloid carcinoma have a better prognosis than other histological subtypes.

References

  1. 1.0 1.1 "Recurrence of thymoma: clinicopathological feat... [J Surg Oncol. 2001] - PubMed - NCBI".
  2. 2.0 2.1 Ogawa, K.; Toita, T.; Uno, T.; Fuwa, N.; Kakinohana, Y.; Kamata, M.; Koja, K.; Kinjo, T.; Adachi, G. (2002). "Treatment and prognosis of thymic carcinoma: a retrospective analysis of 40 cases". Cancer. 94 (12): 3115–9. doi:10.1002/cncr.10588. PMID 12115342. Unknown parameter |month= ignored (help)